Reuters
@Reuters
Top and breaking news, pictures and videos from Reuters. For breaking business news, follow @ReutersBiz. Our daily podcast is here:
Joined March 2007
1.2K Following 26.3M Followers
Nestle is seeking to turn the rise of GLP-1 weight-loss drugs from a threat into a business opportunity, using artificial intelligence and nutritional science to develop products aimed at millions of consumers taking medicines such as Ozempic and Wegovy
Show more
